Skip to content

Comparing of Long Bout and Short Bouts of Similar Volume of Walking in Obese on Weight Loss During a Weight Loss Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02387827
Enrollment
60
Registered
2015-03-13
Start date
2015-02-28
Completion date
2016-02-29
Last updated
2017-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight

Keywords

long bout physical activity, short bout physical activity, Caloric Restriction

Brief summary

The purpose of this present study is to determine if a daily walking program of 50 continuous minutes (long bout) or two 25-minute bouts (short bouts) in similar volume on body weight, abdominal fat mass deposition and cardiometabolic measures in overweight and obese women receiving a low calorie diet for 24 weeks.

Interventions

BEHAVIORALDiet+ short term versus long -term physical activity

Sponsors

University of Nottingham
CollaboratorOTHER
Tehran University of Medical Sciences
CollaboratorOTHER
Novindiet Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Must have Body mass index (BMI) between 27-35 kg/ m². * were sedentary (reported exercising \<20 min/d for the previous 6 month) and healthy * Must be able to have moderate exercise. * Must be interested to have weight loss.

Exclusion criteria

* Participating in a research project involving weight loss or physical activity in the previous six months. * Pregnancy or lactation during the previous 6 months, or planned pregnancy in the next six months. * Taking medication that could affect metabolism or change body weight. * Report heart problems, chest pain, and cancer within the last five years. * Smoking * Menopause * Diagnosis of any chronic disease such as fatty liver, cancer, chemo/radio therapy, heart disease, immune compromised conditions, abnormal thyroid hormone level.

Design outcomes

Primary

MeasureTime frame
weight loss24 weeks
Body mass index reduction24 weeks

Secondary

MeasureTime frame
waist circumference24 weeks
Fasting plasma glucose level24 weeks
lipid profiles24 weeks
Insulin resistance (HOMA)24 weeks

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026